PepGen Inc. (PEPG)
2.47
+0.15
(+6.47%)
USD |
NASDAQ |
Nov 06, 16:00
2.51
+0.04
(+1.62%)
After-Hours: 20:00
PepGen EPS Diluted (TTM) : -1.306 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.306 |
| March 31, 2026 | -1.753 |
| December 31, 2025 | -2.420 |
| September 30, 2025 | -2.836 |
| June 30, 2025 | -2.968 |
| March 31, 2025 | -3.136 |
| December 31, 2024 | -2.84 |
| September 30, 2024 | -2.976 |
| June 30, 2024 | -3.299 |
| March 31, 2024 | -3.247 |
| December 31, 2023 | -3.305 |
| September 30, 2023 | -3.116 |
| Date | Value |
|---|---|
| June 30, 2023 | -2.927 |
| March 31, 2023 | -3.335 |
| December 31, 2022 | -21.58 |
| September 30, 2022 | -21.27 |
| June 30, 2022 | -20.85 |
| March 31, 2022 | -19.91 |
| December 31, 2021 | -1.111 |
| September 30, 2021 | -0.8069 |
| March 31, 2021 | -0.4446 |
| December 31, 2020 | -0.1483 |
| September 30, 2020 | -0.015 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Korsana Biosciences, Inc. | -11.76 |
| IRulya Therapeutics, Inc. | -125.60 |
| Q32 Bio, Inc. | 3.343 |
| Bridgebio Oncology Therapeutics, Inc. | -1232.83 |
| Arrowhead Pharmaceuticals, Inc. | -2.243 |